Skip to main content
Clinical Trials/TCTR20151005001
TCTR20151005001
Completed
Phase 4

Impact on insulin sensitivity and insulin resistance after the conversion from tacrolimus twice daily to extended-release tacrolimus once daily in stable renal transplant recipients

Prajej Ruangkanchanasetr0 sites28 target enrollmentOctober 5, 2015

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
insulin sensitivityinsulin resistance
Sponsor
Prajej Ruangkanchanasetr
Enrollment
28
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 5, 2015
End Date
September 30, 2015
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Prajej Ruangkanchanasetr

Eligibility Criteria

Inclusion Criteria

  • age more than 18 years old
  • renal transplantation
  • stable renal function

Exclusion Criteria

  • critical illness

Outcomes

Primary Outcomes

Not specified

Similar Trials